Acesso livre
Acesso livre

Infectologia

Revisão | Patogênese do SARS-CoV-2.

10 Mai, 2022 | 12:37h

SARS-CoV-2 pathogenesis – Nature Reviews Microbiology

 

Comentário no Twitter

 


Revisão | Superação da resistência do Stenotrophomonas maltophilia para uma abordagem terapêutica mais racional.

10 Mai, 2022 | 12:18h

Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach – Open Forum Infectious Diseases


Revisão | Testagem não invasiva e marcadores substitutos nas doenças fúngicas invasivas.

10 Mai, 2022 | 12:16h

Non-invasive Testing and Surrogate Markers in Invasive Fungal Diseases – Open Forum Infectious Diseases


Estudo de efetividade comparativa | Oxigenação extracorpórea venovenosa em pacientes com insuficiência respiratória associada a Covid-19 aguda.

6 Mai, 2022 | 17:42h

Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study – The BMJ

 

Comentário no Twitter

 


Descartados os suspeitos comuns (Hepatites A-E), cientistas tentam desvendar o mistério dos casos de hepatite viral em crianças.

6 Mai, 2022 | 17:41h

With usual suspects ruled out, disease detectives try to crack mystery of viral hepatitis cases in kids – STAT

Conteúdos relacionados:

Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022 – Morbidity and Mortality Weekly Report

The CDC and WHO Have Reported an Unusual Cluster of Severe Pediatric Hepatitis Cases – Science-Based Medicine

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press


M-A | Eficácia e efetividade das vacinas contra SARS-CoV-2.

6 Mai, 2022 | 17:36h

Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis – Vaccines


Estudo de coorte retrospectiva | Desfecho de tratamento com penicilina G ou cloxacilina na bacteriemia por Staphylococcus aureus suscetível à penicilina.

6 Mai, 2022 | 17:11h

Treatment outcome with penicillin G or cloxacillin in penicillin susceptible Staphylococcus aureus bacteraemia – A retrospective cohort study – International Journal of Antimicrobial Agents

 

Comentário no Twitter

 


OMS alerta para cursos medicamentosos mais curtos para tuberculose resistente.

6 Mai, 2022 | 17:07h

WHO calls for shorter drug course for resistant TB – CIDRAP

Comunicação rápida: Key changes to the treatment of drug-resistant tuberculosis – World Health Organization


Falha do Paxlovid como medida preventiva levanta questionamentos, mas os médicos ainda o consideram como um tratamento.

6 Mai, 2022 | 16:58h

Paxlovid’s failure as a preventative measure raises questions, but doctors still back it as a therapeutic – STAT


Tratamento bacteriofágico da infecção disseminada cutânea por Mycobacterium chelonae.

6 Mai, 2022 | 16:43h

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection – Nature Communications

 

Comentário no Twitter (fio – clique para saber mais)

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.